Tyligand Bioscience (Shanghai) Limited
3 clinical trials · Sponsor
◉ Watch Tyligand Bioscience (Shanghai) Limited
| Record | Firm | Date |
|---|---|---|
| TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (NCT05842785) | Tyligand Bioscience (Shanghai) Limited | 2023-07-26 |
| TSN084 Treating Patients With Advanced Malignant Tumors (NCT06386705) | Tyligand Bioscience (Shanghai) Limited | 2022-07-20 |
| Phase I Study of TSN084 in Patients With Advanced Malignant Tumors. (NCT05300438) | Tyligand Bioscience (Shanghai) Limited | 2022-02-18 |
Track Tyligand Bioscience (Shanghai) Limited automatically
Every clearance here is in the API, with alerts when new ones post.